William H. Liggett

1.6k citations
16 papers · 1.2k indexed · 1 hit paper · h-index 10
Topics
Advanced Breast Cancer Therapies (3 papers)Cancer Treatment and Pharmacology (3 papers)Lung Cancer Research Studies (3 papers)
Partner nations
United StatesCanada

In The Last Decade

William H. Liggett

16 papers receiving 1.2k citations

Hit Papers

Role of the p16 tumor suppressor gene in cancer.19982026200720161998100200300400500

Peers

William H. Liggett
Comparison fields: 5 of 83
  • Oncology 588
  • Molecular Biology 522
  • Pulmonary and Respiratory Medicine 411
  • Otorhinolaryngology 273
  • Cancer Research 139
Replace Jamel Daoud with:
Jamel Daoud Tunisia
Asawari Patil India
Stavros Vassiliou Greece
Juan J. Grau Spain
P Maxwell United Kingdom
Spyridoula Derka Greece
N. K. Shukla India
Scott A. Kono United States
Preston D. Steen United States
Paul Chih-Hsueh Chen Taiwan
William H. Liggett relative to Jamel Daoud Tunisia Jamel Daoud's profile →
Citations per field
00.5×1.5×2.2×
Jamel Daoud · 1×
Citations per year

Countries citing papers authored by William H. Liggett

Since Specialization
Citations

This map shows the geographic impact of William H. Liggett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Liggett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Liggett more than expected).

Fields of papers citing papers by William H. Liggett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Liggett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Liggett. The network helps show where William H. Liggett may publish in the future.

Co-authorship network of co-authors of William H. Liggett

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Liggett. A scholar is included among the top collaborators of William H. Liggett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Liggett. William H. Liggett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 6
2 8
3 1
4 3
5 26
6 5
7 3
8 13
9 36
10 302
11
Role of the p16 tumor suppressor gene in cancer.breakdown →
563
12
p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer.
71
13
p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro.
84
14 12
15 38
16 27

About William H. Liggett

William H. Liggett is a scholar working on Otorhinolaryngology, Oncology and Hematology, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Otorhinolaryngology (273 citations), Oncology (588 citations) and Pulmonary and Respiratory Medicine (411 citations). William H. Liggett has collaborated with scholars based in United States and Canada. Frequent co-authors include David Sidransky, Mark M. Schubert, Douglas E. Peterson, Francis G. LeVeque, Janet Wittes, Stephen T. Sonis, June Eilers, Joel B. Epstein, Fred K. L. Spijkervet and Joel S. Greenberger. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026